InvestmentHealthcare
OrbiMed co-leads $200 million financing for Star Therapeutics
Star Therapeutics, a South San Francisco biotech developing antibody therapies, raised $200 million in a financing co-led by OrbiMed and Janus Henderson Investors.
- Target
- Star Therapeutics
- Sponsor
- OrbiMed
- Value
- $200 million
- Source
- STAR Therapeutics